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Summary Characteristic gene rearrangements are present in most non-Hodgkin's lymphomas (NHL). These
are usually detected by Southern blotting techniques. In this study, the ability of the polymerase chain reaction
(PCR) to detect the t(14;18) chromosomal translocation and immunoglobulin heavy chain (IgH) gene
rearrangement was evaluated. DNA from 14 follicular and 42 diffuse B-cell lymphomas was examined using
oligonucleotide primers specific for opposing sides ofthe IgH gene rearrangement on chromosome 14 (towards
conserved VH and JH sequences) and opposing sides of the t(14;18) chromosomal translocation (towards the
major breakpoint region of the bcl-2 gene on chromosome 18 and conserved JH sequence on chromosome 14).
The t(14;18) translocation was detected in 57% of follicular lymphomas and 21% ofdiffuse B-cell lymphomas.
Clonal IgH gene rearrangements using PCR were detected in 50% follicular and 52% of the diffuse
lymphomas. Either or both of these rearrangements were detected in 93% follicular and in 59% of diffuse
lymphomas. PCR is a rapid and easy technique that can detect the abnormal rearrangement of the bc1-2 gene
and clonal IgH rearrangement, indicating the presence of lymphoma. This may be of benefit in monitoring
response to therapy and in predicting prognosis in this disease.
Malignant lymphomas are a heterogeneous group of tumours
with varied clinicopathological features, response to therapy
and overall survival. The success of chemotherapy in curing
over 50% of patients with intermediate and high grade
lymphomas poses new challenges in the management of these
tumours (Fisher et al., 1991; Jagannath et al., 1985). Identify-
ing tumour specific prognostic factors that can accurately
monitor or predict the behaviour of individual lymphomas
may select patients who can benefit from more or less inten-
sive therapy, reduce the morbidity of therapy for some and
increase the potential for cure in others. Accurate monitoring
of disease may detect residual disease in patients apparently
in remission and thus detect recurrence at an earlier stage of
tumour progression. Our present understanding of the molec-
ular biology of lymphomas has identified normal and abnor-
mal molecular events which may be used to monitor the
disease, understand the pathogenesis and predict prognosis.
During maturation of normal and malignant B-lympho-
cytes somatic rearrangement of DNA occurs in the immuno-
globulin heavy chain (IgH) gene (Tonegawa, 1983). B-cell
lymphomas are clonal tumours with genetically identical cells
and therefore all the cells have identical immunoglobulin (Ig)
gene rearrangements thus providing a unique marker for
monitoring disease (Waldmann, 1987).
A number of chromosomal translocations that occur in
B-cell Non Hodgkin's lymphoma (NHL) are associated with
the juxtaposition of oncogenes from their original chromo-
somes, to sites adjacent to antigen receptor genes e.g. the
immunoglobulin gene (Yunis et al., 1982; Dalla-Favera et al.,
1982; Taub et al., 1982; Croce & Nowell, 1985).
The t(14;18) chromosomal translocation, occuring in over
80% of follicular lymphomas, and in approximately 10-30%
of diffuse lymphomas, is the single most common chromo-
somal abnormality occurring in NHL (Yunis et al., 1987). In
this translocation the bcl-2 oncogene is translocated from
chromosome 18 to a site juxtaposing the joining (JH) region
of the IgH gene on chromosome 14 (Tsujimoto et al., 1985a;
Cleary & Sklar, 1985; Bakhshi et al., 1985; Cleary et al.,
1986a).
These chromosomal changes and abnormalities are detect-
able using cytogenetics, Southern blotting and more recently
the polymerase chain reaction (PCR). While cytogenetics and
Southern blotting provide useful information, they have
limitations. Karyotype analysis, which provided the original
information on chromosomal abnormalities (Yunis, 1981;
Rowley & Fukuhara, 1980) is a lengthy procedure and
requires highly specialised interpretation. At the molecular
DNA level, Southern blotting is also used to identify specific
chromosomal changes and to detect clonal Ig rearrange-
ments, however this technique required the use of radio-
isotopes and is also time consuming.
The PCR is a rapid and sensitive method in which identi-
fied and targeted sequences of DNA are exponentially
amplified and thereby become detectable. The efficient ampli-
fication of a known DNA sequence requires the use of DNA
primer sequences on either side of the targeted DNA
sequence (Saiki et al., 1988). Using PCR primers which
anneal to opposing sides of targeted areas of the Ig gene
rearrangements and chromosomal translocations, it is possi-
ble to amplify a sequence of DNA that is unique to the
lymphoma cells.
The more common rearrangements identified in B-cell
NHL include clonal IgH rearrangement and the t(14;18)
translocation. In this study the ability of PCR assays to
identify these specific molecular events in patients with B-cell
NHL was evaluated. The detection of these and other molec-
ular abnormalities in NHL may help to understand its patho-
genesis, be of prognostic significance and be of benefit in
monitoring the disease.
Materials and methods
Patient materials
DNA was extracted using standard techniques (Sambrook et
al., 1989) from snap frozen, lymph node tumour biopsy
specimens, obtained from 56 patients. All tumours were con-
firmed histopathologically to be non-Hodgkin's lymphomas
and the B-cell phenotype was confirmed by immunohisto-
chemistry (Picker et al., 1987).
Primers
Clonal rearrangement of the IgH gene was detected, by using
two primers to amplify the DNA sequence across the Ig gene
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VH-DH-JH rearrangement (McCarthy et al., 1990) (Figure 1).
An oligonucleotide primer complementary to the majority of
variable segments (VH consensus sequence) was used in con-
junction with a consensusjoining region (JH) oligomer. In the
non-rearranged immunoglobulin heavy chain gene, the VH
and JH regions are separated by a distance of 100 kb and are
thus, not amenable to amplification (Tonegawa, 1983).
Approximately 60% of breakpoints on chromosome 18
occur at the major breakpoint region (MBR) over a 150 bp
region in the bcl-2 gene (Cleary et al., 1986b; Lipford et al.,
1987). The presence of t(14;18) was detected using two oligo-
nucleotide primers, one complementary to the bcl-2 gene
close to the MBR and the JH consensus sequence, to amplify
the DNA sequence across the t(14;18) breakpoint fragment,
i.e. bcl-2-JH rearrangement (Lee et al., 1987; Crescenzi et al.,
1988) (Figure 1). In normal genomic DNA the bcl-2 gene and
JH region would be on different chromosomes and thus not
exponentially amplifiable by PCR. The DNA sequences of
the primers used are shown in Table I.
PCR conditions
One jig purified DNA was subjected to 45 cycle PCR ampli-
fication using the Perkin-Elmer DNA thermal cycler. The
reaction mix (100fil) contained 10 mM Tris-Cl, 1.5 mM
MgCl2, 50 mM KCI, 0.3iLM (primers 1 and 2, Table I) or
0.21LM (primers 2 and 3, Table I), 0.2 mM each of dATP,
dCTP, dGTP and dTTP, 2.5 U Taq polymerase (Amplitaq,
Cetus) and 1 ,tg DNA template. The reaction mixture was
overlaid with 60 gl of light mineral oil (Sigma). The PCR
cycle consisted of denaturation at 94°C for 2 min, annealing
at 61°C for 3 min and synthesis at 72°C for 3 min.
Table I PCR primer sequences
Primers Sequences
1.VH 5' CTG-TCG-ACA-CGG-CCG-TGT-ATT-AGT-G 3'
2.JH 5' ACC-TGA-GGA-GAC-GGT-GAC-CAG-GGT 3'
3. bcl-2 (MBR) 5' TTA-GAG-AGT-TGC-TIT-ACG-TG 3'
4. bcl-2 (internal hybridisation probe, alkaline phosphatase labelled)
5' GCC-TGT-TTC-AAC-ACA-GAC-CC 3'
VHn
PCR products were fractionated on nondenaturing 6%
polyacrylamide gels in TBE buffer for 2.5 h at 170 V, stained
with ethidium bromide and viewed by UV transillumination.
Amplification of the bcl-2 breakpoint fragment, was con-
firmed by hybridisation with an internal primer (4) for bcl-2
(Table I) (alkaline phosphatase-linked; E-link., Cambridge
Research Biochemicals) following transfer of PCR products
by Southern blotting (Southern, 1975; Nguyen, 1989) to
Hybond N+(Amersham).
Sample which had known rearranged bcl-2 genes, as
detected by Southern blotting using the bcl-2 probe (b) (Tsu-
jimoto et al., 1985b) towards the MBR region, were used as
positive controls for the t(14;18) translocation. For clonal
B-cell populations, samples with known IgH rearrangement
using the JH probe (Flanagan & Rabbitts, 1982) were used as
positive controls. Normal tonsilar tissue and reaction mix in
which no DNA was added, were also amplified by PCR as
negative controls.
Standard precautions were taken to guard against cross-
contamination of amplified material which was physically
separated from unamplified material at all times (Kwok &
Higuchi, 1989; Kwok, 1990).
Results
DNA from 56 biopsy specimens obtained from patients with
confirmed NHL, including 42 diffuse lymphomas and 14
follicular lymphomas was subjected to PCR amplification
using the bcl-2IJH and VH/JH primers.
The t(14;18) translocation was detected in 8/14 (57%) of
follicular lymphomas and 9/42 (21%) of the diffuse B-cell
lymphomas. In Figure 2 examples of the PCR ampified
breakpoint fragments across the t(14;18) translocation junc-
tion are shown for a number of lymphoma samples (lanes
1-7). From other studies, it is known that the bcl-2IJH
breakpoint fragments vary in size between 100-300 bp in
length (Shibata et al., 1990). Under the PCR conditions, used
with an annealing temperature of 61°C, background ampli-
fication products consistently appear at approximately 600 bp
and greater in most samples (Figure 2; lanes 3-11).
Amplification of bcl-2IJH products was confirmed by
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Figure 1 Schematic representation of strategy for PCR amplification of immunoglobulin heavy chain gene VH-JH rearrangement
(chromosome 14) using primers 1 and 2 (Table I) and t(14;18) translocation involving the bcl-2 oncogene (chromosome 18) and JH
region of the immunoglobulin heavy chain gene (chromosome 14) using primers 3 and 2 (Table I).
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Figure 2 PCR amplification products of the bcl-2-JH breakpoint
fragments (MBR) on ethidium bromide stained polyacrylamide
gels (6%) using the primers 3 and 2 (Table I) in lymph nodes
from patients with B-cell NHL's. Bands in the size region 100-
300 bp are indicative of the t(14;18) chromosomal translocation.
Base-pair size markers pGem (M); positive control with known
t(14;18) translocation (lane 1); positive samples are from folli-
cular lymphoma patients (lanes 2, 3, 4, 5) and diffuse NHL (lanes
6, 7); negative samples are from follicular NHL (lane 8), diffuse
NHL (lanes 9, 10) and normal tonsil (lane 11).
Southern blotting using an internal bcl-2 probe (Figure 3;
positive samples lanes 1-7). No hybridisation was observed
in the negative samples (lanes 8-11). In the positive samples
(lanes 3, 4, 5, 7) there is hybridisation of larger PCR pro-
ducts (-500 bp or greater). This is probably due to the use
of the consensus JH primer which may anneal to other adja-
cent JH regions, if present, as a consequence of the IgH
rearrangement (see Figure 1). This would result in the
appearance of larger PCR products, however, sequencing
information would be necessary to confirm this. The slight
variation in size of the breakpoint fragments between individ-
ual samples is due to firstly, the variation in the exact loca-
tion of the breakpoint in the bcl-2 gene and secondly, the
introduction of extranucleotide regions (N-segments) during
the rearrangement process of the IgH gene DH-JH regions,
during which the t(14;18) translocation is thought to occur
(Desiderio et al., 1984).
Using the consensus VH and JH primers, amplification of
the VH-DH-JH junction was carried out. In 50% (n = 14) of
follicular and 52% (n = 42) of diffuse lymphomas amplified
breakpoint fragments, indicative of clonal B-cell populations,
were observed using the VH/JH primers. In clonal B-cell
populations this results in the amplification of a single or
double band (Figure 4). Again, due to the insertion of the
extranucleotide N-regions during the rearrangement process
there is variation in the size of the breakpoint fragments
(75-200 bp) obained between individual lymphoma samples.
Larger bands are also observed in some samples with the
VH/JH primers, which as described above could be due to
priming of adjacent JH regions or due to background ampli-
fication products (although, they do not appear in the con-
trol tonsil tissue (T)). Two VH/JH breakpoint fragments are
apparent in lane 4 (Figure 4) and may represent IgH rear-
rangement ofboth alleles or the presence of two B-cell clones
in the tumour. In both diffuse and follicular lymphoma
samples, 14% had breakpoint amplification products with
both sets of primers.
The ability of PCR to detect the presence of a malignant
clone oflymphocytes in tissue samples may be potentially the
most valuable application of this technique. Combining the
results from using either or both sets of primers to detect the
t(14;18) translocation and clonal B-cell populations, for indi-
vidual tissue samples, it was possible to detect the malignant
clone in 93% follicular lymphomas and 59% of diffuse B-cell
lymphomas (Table II).
Discussion
Our results demonstrate the ability of the PCR, to detect the
presence of the t(14;18) translocation, and clonal IgH rear-
rangements in tissue from diffuse and follicular lymphomas.
The presence of the t(14;18) translocation was demon-
strated using a primer specific for the major breakpoint
region. The majority of t(14;18) translocations on chromo-
some 18 occur within this well defined region which has been
shown by sequence analysis to encode a portion of the 3'
untranslated region of the bcl-2 gene (Cleary et al., 1986b;
Lipford et al., 1987). On chromosome 14 the breakpoints
have been shown to occur with or near an IgH joining
segment, and a single consensus JH primer was used on this
side of the breakpoint for PCR amplification. Using this set
of primers for the MBR, the t(14;18) translocation was
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Figure 3 Southern blot ofpolyacrylamide gel (Figure 2) showing
hybridisation of bcI-2-JH breakpoint fragments, indicative of the
t(14;18) translocation using the internal bcl-2 alkaline phospha-
tase labelled primer (4) (Table I). Positive control with known
t(14;18) translocation (lane 1); positive samples are from folli-
cular lymphoma patients (lanes 2, 3, 4, 5) and diffuse NHL (lanes
6, 7); negative samples are from follicular NHL (lane 8), diffuse
NHL (lanes 9, 10) and normal tonsil (lane 11).
Figure 4 PCR amplification products of the VH-JH breakpoint
fragments on ethidium bromide stained polyacrylamide gels (6%)
using the primers 1 and 2 (Table I) in lymph nodes from patients
with B-cell NHL's. Bands in the size region 75-200 bp are
indicated of a monoclonal B-cell population. Base-pair size
markers OX174 Hae (M); positive samples are from follicular
lymphoma (lanes 2, 3, 6, 7) and diffuse B-cell lymphomas (lanes
4, 5, 8, 9); negative samples include tonsil (T), Hodgkin's disease,
reactive lymph node (lanes 10, 11).
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Table II Summary of results of Follicular and Diffuse NHL patients with t(14;18) translocations and clonal B-cell
populations as determined by specific PCR assays
PCR Amplification
NHL subtype No. t(14;18) translocation (MBR) Clonal B-cell Amplification concurrently Identification of
bcl-2/JH VH/JH bcl-2/JH and VH/JH malignant clone
Follicular 14 8/14 (57%) 7/14 (50%) 2/14 (14%) 13/14 (93%)
Diffuse 42 9/42 (21%) 22/42 (52%) 5/42 (14%) 25/42 (59%)
detected in 57% of follicular lymphomas. This correlates
with the incidence found using Southern blotting for the
MBR region (Weiss et al., 1987). The t(14;18) translocation
occurs in approximately 85% of follicular lymphomas. How-
ever, a significant proportion of translocations (up to 25%)
occur at a second site on chromosome 18, distal to the MBR
region by 20 kb. This site is known as the minor cluster
region (MCR) and would require a separate MCR specific
primer, in conjunction with the JH primer, to allow PCR
amplification (Cleary et al., 1986a; Ngan et al., 1989).
Each individual lymphocyte has a unique IgH gene rear-
rangement with a specific VH-DH-JH sequence. Each malig-
nant lymphoma is composed of a clone of cells, all with the
same IgH rearrangement. Using primers specific for consen-
sus regions within the variable and joining segments, clonal
IgH gene rearrangements detected the presence of a malig-
nant clone in approximately 50% of both follicular and
diffuse lymphomas. Our failure to detect a malignant clone in
all cases of B-cell NHL is probably due to the heterogeneity
of the targeted VH-DH-JH DNA sequences. Detection of
clonal IgH gene rearrangements can thus provide valuable
information for individual patients, but is of limited sen-
sitivity as a tumour marker in detecting and monitoring
disease in all B-cell NHL's.
However, when the results of both PCR assays are com-
bined for each patient, we found that the malignant clone
could be detected in 93% of follicular and 59% of diffuse
lymphomas. This suggests that using more than one set of
primers in follicular lymphomas is of benefit in detecting and
monitoring disease. A valuable use of PCR has been demon-
strated by Gribben et al. (1991) in the detection of the
t(14;18) translocation in marrow samples prior to transplan-
tation. They presented strong evidence that reinfusion of
malignant cells contributed to relapse in autologous marrow
transplantation. The absence of residual lymphoma after
immunologic purging of autologous marrow prior to trans-
plantation was associated with a significant increase in
disease-free survival and reduced relapse rate in these
patients.
The significance of the t(14;18) translocation in the onco-
genesis of NHL is not fully understood. It is thought to
occur as an early event during IgH rearrangement. The trans-
location results in the increased expression of the bcl-2 onco-
gene, and this increased bcl-2 oncoprotein expression has
been shown to promote survival of B-cells (McDonnell et al.,
1991). The prognostic value of bcl-2 rearrangement in diffuse
NHL remains controversial (Yunis et al., 1989). Detected in
between 10-30% diffuse lymphomas, the bc1-2 rearrange-
ment correlates with a poor response to therapy and shorter
survival in a number of studies.
Our results for detection of MBR using the specific primers
are similar to those found in other studies (Crescenzi et al.,
1988; Shibata et al., 1990). We have also used two rounds of
PCR amplification and single or nested sets ofVH/JH primers,
as suggested by Wan et al. (1990), but did not find that it
significantly increased the detection rate of IgH rearrange-
ments in B-cell NHL (data not shown). Due to the inclusion
of variable N-regions and JH segments, bcl-2 breakpoints are
highly variable, as shown by direct sequencing studies (Eick
et al., 1990; Cotter et al., 1991). Clearly, all IgH gene re-
arrangements cannot be detected by a single set of primers,
because of the variability in the targeted sequences, and the
frequent occurrence of specific translocations at this locus. In
order to reliably identify the malignant clone in all lym-
phoma samples, groups and nested sets of appropriate
primers would be required.
The great advantage of PCR is its unique sensitivity and
specificity in detecting targeted sequences of DNA and RNA
in both fresh and paraffin-embedded tissue. It is easier to use
and more widely applicable than either Southern blotting or
karyotyping. In comparison to these techniques, analysis by
PCR is much quicker and less labour intensive with results in
less than 24 h as compared to 5-10 days. Apart from con-
tamination, the other major drawbacks with PCR are, the
inability to accurately quantify the volume of cells with the
targeted abnormality and, because of the specificity of the
oligonucleotide primers, any variation in the targeted
sequence of DNA can give a false negative result.
The ease and rapidity with which the t(14;18) translocation
and IgH rearrangements can be detected by PCR is useful in
the detection of lymphoma, in the differential diagnosis of
reactive from malignant infiltrations, and in differentiating
between lymphoid and non-lymphoid tumours. Our study
suggests that combining PCR reactions to detect the t(14;18)
translocation and IgH rearrangements will allow detection of
almost all follicular lymphomas (93%). Detecting the t(14;18)
translocation may be of prognostic significance in patients
with diffuse NHL. As a result of the sensitivity of this
technique, the positive detection of VH/JH or bcl-2 rear-
rangements may be used in individual patients to monitor
disease and determine their response to therapy. This may be
of particular importance in detecting minimal disease in
patients considered for autologous bone marrow transplanta-
tion.
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